• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Novo Nordisk increases commitment to cell therapies

biospectrumasiaMay 17, 2018

Tag: Novo Nordisk , Cell , BioLamina

BioLamina and collaborators have partnered with Novo Nordisk, a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell based therapies based on Biolaminins, human recombinant laminin cell culture matrices, developed and produced by BioLamina.

Novo Nordisk is increasing its commitment to cell therapies, including areas outside of diabetes. The three cell therapy projects they have licensed are all based on BioLamina technology. These projects aim to treat Parkinson's disease, heart failure and loss of vision, all severe chronic conditions.

Malin Parmar's research group at Lund University and Karl Tryggvason's research group at Duke-NUS in Singapore have developed potential cell therapies based on BioLamina's unique Biolaminin matrices. Both groups have signed research and potential licensing agreements with Novo Nordisk with the aim to develop these projects further together with Novo Nordisk, enabling a translation of cell therapy pre-clinical studies, to clinical trials and eventually towards patient treatments.

Register as Visitor to CPhI China 2018!

Previous:Japan approves stem cell based trials for heart treatment

Next:US, China to sign MoU for Biotechnology Innovation Centre

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Novo Nordisk increases commitment to cell therapies | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

BT-250 Cellophane Overwrapping Machine

BT-250 Cellophane Overwrapping Machine
DEAE-Cellulose

DEAE-Cellulose
Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral
Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)

Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
BT-250/BT-400C  Cellophane paper(film)Box-type Tridimensional Packing Machine

BT-250/BT-400C  Cellophane paper(film)Box-type Tridimensional Packing Machine
Carboxymethylcellulose Sodium

Carboxymethylcellulose Sodium
HPMC (Hydroxy Propyl Methyl Cellulose)

HPMC (Hydroxy Propyl Methyl Cellulose)
CO2 Cell Incubator WJ-2

CO2 Cell Incubator WJ-2
Ethyl Cellulose (EC)

Ethyl Cellulose (EC)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service